LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations Among 187 patients identified (median follow-up, 22.4 ...

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Artificial intelligence (AI) ...

Many patients with IBC in LMICs are not receiving TMT. Barriers to diagnosis and treatment were at least partially related to limited providers' comfort level and knowledge, suggesting that ...

Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing Administration The concept of time toxicity of cancer treatment, defined as ...

Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic Treatment We analyzed follow-up CT reports from patients ...

Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients The three-center Mayo Clinic experience with ...

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer–Associated Germline Pathogenic Variants in Mexico Moderate hypofractionation (MHF) offers ...

Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients Of the 1,888 patients with PDAC, 1,162 completed ...

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma ...

Cancer remains a widespread and significant global health issue, with consequential impacts on individuals, families, and societies across the globe. Although there have been noteworthy advancements ...

Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients The following represents disclosure information ...